|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 25/06 | (2006.01) |
| A61K 31/225 | (2013.01) | ||
| A61K 31/12 | (2006.01) | ||
| A61P 25/06 | (2018.01) | ||
| A61K 31/21 | (2006.01) | ||
| A61K 31/231 | (2013.01) | ||
| A61K 31/231 | (2006.01) |
| (11) | Number of the document | 3558458 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17884757.0 |
| Date of filing the European patent application | 2017-11-30 | |
| (97) | Date of publication of the European application | 2019-10-30 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/063832 |
| Date | 2017-11-30 |
| (87) | Number | WO 2018/118369 |
| Date | 2018-06-28 |
| (30) | Number | Date | Country code |
| 201615389828 | 2016-12-23 | US |
| (72) |
HASHIM, Sami , US
|
| (73) |
Neuroenergy Ventures, Inc. ,
Gellis Law Group
641 Lexington Avenue , 14th Floor, New York, NY 10022,
US
|
| (54) | GLYCERYL 3-HYDROXYBUTYRATES FOR MIGRAINE SYMPTOM MANAGEMENT |
| GLYCERYL 3-HYDROXYBUTYRATES FOR MIGRAINE SYMPTOM MANAGEMENT |